CN118165978A - Sequential nano catalyst and preparation method thereof - Google Patents
Sequential nano catalyst and preparation method thereof Download PDFInfo
- Publication number
- CN118165978A CN118165978A CN202410277726.3A CN202410277726A CN118165978A CN 118165978 A CN118165978 A CN 118165978A CN 202410277726 A CN202410277726 A CN 202410277726A CN 118165978 A CN118165978 A CN 118165978A
- Authority
- CN
- China
- Prior art keywords
- graphene oxide
- mesoporous organic
- organic silicon
- silicon oxide
- pmo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011943 nanocatalyst Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 85
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 64
- 229910052814 silicon oxide Inorganic materials 0.000 claims abstract description 59
- 108010015776 Glucose oxidase Proteins 0.000 claims abstract description 49
- 239000004366 Glucose oxidase Substances 0.000 claims abstract description 49
- 229940116332 glucose oxidase Drugs 0.000 claims abstract description 49
- 235000019420 glucose oxidase Nutrition 0.000 claims abstract description 49
- 229910021389 graphene Inorganic materials 0.000 claims abstract description 48
- 238000002156 mixing Methods 0.000 claims abstract description 34
- 238000006482 condensation reaction Methods 0.000 claims abstract description 20
- 239000002904 solvent Substances 0.000 claims abstract description 17
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 16
- 230000004913 activation Effects 0.000 claims abstract description 15
- 239000003054 catalyst Substances 0.000 claims abstract description 11
- 230000003213 activating effect Effects 0.000 claims abstract description 8
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 8
- 239000000243 solution Substances 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 229910001868 water Inorganic materials 0.000 claims description 19
- 239000011259 mixed solution Substances 0.000 claims description 15
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 13
- 229910052710 silicon Inorganic materials 0.000 claims description 13
- 239000010703 silicon Substances 0.000 claims description 13
- 239000000377 silicon dioxide Substances 0.000 claims description 13
- 238000000707 layer-by-layer assembly Methods 0.000 claims description 11
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 claims description 9
- 239000004094 surface-active agent Substances 0.000 claims description 9
- 238000006068 polycondensation reaction Methods 0.000 claims description 8
- 239000012190 activator Substances 0.000 claims description 5
- 230000003301 hydrolyzing effect Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 claims 7
- 230000000694 effects Effects 0.000 abstract description 34
- 102000003992 Peroxidases Human genes 0.000 abstract description 11
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 11
- 108040007629 peroxidase activity proteins Proteins 0.000 abstract description 10
- -1 amino-carboxyl Chemical group 0.000 abstract description 5
- 238000006555 catalytic reaction Methods 0.000 abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- 238000005119 centrifugation Methods 0.000 description 12
- 238000002835 absorbance Methods 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 8
- 238000000605 extraction Methods 0.000 description 7
- 230000003197 catalytic effect Effects 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 239000002105 nanoparticle Substances 0.000 description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical group [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 239000002086 nanomaterial Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical group [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 101710154526 Lytic chitin monooxygenase Proteins 0.000 description 2
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 108010046301 glucose peroxidase Proteins 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 239000013335 mesoporous material Substances 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000007669 thermal treatment Methods 0.000 description 2
- 238000004627 transmission electron microscopy Methods 0.000 description 2
- VTHOKNTVYKTUPI-UHFFFAOYSA-N triethoxy-[3-(3-triethoxysilylpropyltetrasulfanyl)propyl]silane Chemical compound CCO[Si](OCC)(OCC)CCCSSSSCCC[Si](OCC)(OCC)OCC VTHOKNTVYKTUPI-UHFFFAOYSA-N 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108010020056 Hydrogenase Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002789 catalaselike Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010981 drying operation Methods 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000013385 inorganic framework Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013384 organic framework Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000007626 photothermal therapy Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- XJKVPKYVPCWHFO-UHFFFAOYSA-N silicon;hydrate Chemical compound O.[Si] XJKVPKYVPCWHFO-UHFFFAOYSA-N 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J21/00—Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
- B01J21/18—Carbon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
- C12Y101/03004—Glucose oxidase (1.1.3.4)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Catalysts (AREA)
Abstract
The invention provides a sequential nano catalyst and a preparation method thereof, and belongs to the technical field of catalysts. The invention provides a preparation method of a sequential nano catalyst, which comprises the following steps: mixing graphene oxide coated mesoporous organic silicon oxide, a first solvent and an activating agent, and performing carboxyl activation treatment to obtain activated graphene oxide coated mesoporous organic silicon oxide; and mixing the activated graphene oxide coated mesoporous organic silicon oxide with glucose oxidase, and performing condensation reaction to obtain the sequential nano catalyst. According to the invention, firstly, carboxyl activation treatment is carried out on the graphene oxide coated mesoporous organic silicon oxide, and then glucose oxidase is connected to the surface of the mesoporous organic silicon oxide through amino-carboxyl condensation reaction, so that the glucose oxidase in the sequential nano catalyst exerts glucose oxidase activity, and the graphene oxide exerts peroxidase activity and photo-thermal property, so that a nano reagent with sequential catalysis is formed.
Description
Technical Field
The invention belongs to the technical field of catalysts, and particularly relates to a sequential nano catalyst and a preparation method thereof.
Background
The enzyme has active catalytic performance and substrate specificity, and is important to ensure the functions and metabolism of cells. Most natural enzymes are proteins or RNAs, which suffer from the disadvantages of instability, high cost and complex synthesis. With the development of nanotechnology, some nanomaterials with enzyme-like activity have been developed, called "nanoenzymes". Compared with natural enzymes, the nano-enzyme has higher stability and lower cost, and can be produced in batches. Different nanoenzymes may exert different enzyme activities, such as catalase-like activity, peroxidase-like activity, oxidase-like activity, and superoxide dismutase-like activity. Nanoezymes have been studied in biomedical analysis, imaging, environmental protection, and the like.
The characteristics of the tumor microenvironment include excessive hydrogen peroxide, hypoxia, acidity, low activity of hydrogenase and the like. The nano enzyme can utilize the characteristics of tumor microenvironment to exert corresponding enzyme activity and generate cytotoxicity molecules such as Reactive Oxygen Species (ROS), including singlet oxygen (1O2), superoxide anions (O 2), hydroxyl radicals (OH) and the like, which are beneficial to killing tumor cells.
Graphene Oxide (GO) is a two-dimensional platelet nanomaterial with excellent chemical/mechanical stability, strong Near Infrared (NIR) region absorption, good thermal and electrical conductivity. It has been widely studied in the fields of nanoelectronics, biosensors, drug delivery, photothermal therapy, and bioimaging. In addition, GO also exhibits peroxidase-like activity, which can catalyze the generation of hydroxyl radicals from H 2O2. Based on this property, GO has been studied for glucose detection, but its use in tumor therapy has not been fully studied, and thus it is necessary to further explore its antitumor potential. However, there are some challenges in the use of GO for organisms, and studies have shown that GO has a concentration-dependent cytotoxicity on human cells, which is thought to be caused by the direct physical damage to cell membranes by the sharp edges of GO.
Mesoporous organic silica (PMO) is a mesoporous material with organic and inorganic frameworks. The modified mesoporous material has larger specific surface area, ordered mesopores, surface characteristics easy to modify and good biocompatibility and biodegradability. Many studies have constructed multifunctional PMO-based nanosystems that can be used for drug delivery, bioimaging, combined treatment of tumors, etc. The shape and size of the PMO can be adjusted relatively easily by optimizing the amount of surfactant, the ratio of ethanol and water, the silicon source dose, and the concentration of ammonia. Studies have reported spherical, egg yolk, double, deformable hollow and microminiature PMO, etc. Research shows that GO can be coated on the surface of spherical mesoporous silica nano particles to obtain a multifunctional nano platform which is used for tumor treatment and has good biocompatibility, but does not have sequential catalytic activity. Therefore, constructing a catalyst with sequential catalytic activity for the combined synergistic treatment of tumors becomes a technical problem to be solved in the art.
Disclosure of Invention
The invention aims to provide a sequential nano catalyst and a preparation method thereof. GOD in the sequential nano-catalyst prepared by the preparation method provided by the invention exerts glucose oxidase activity, GO exerts peroxidase activity and photo-thermal property, and a sequentially catalyzed nano-reagent is formed.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides a preparation method of a sequential nano catalyst, which comprises the following steps:
(1) Mixing graphene oxide coated mesoporous organic silicon oxide, a first solvent and an activating agent, and performing carboxyl activation treatment to obtain activated graphene oxide coated mesoporous organic silicon oxide;
(2) And (3) mixing the activated graphene oxide coated mesoporous organic silicon oxide obtained in the step (1) with glucose oxidase, and performing condensation reaction to obtain the sequential nano catalyst.
Preferably, the preparation method of the graphene oxide coated mesoporous organic silicon oxide in the step (1) comprises the following steps:
1) Mixing a surfactant, a second solvent and a catalyst to obtain a mixed solution;
2) Mixing the mixed solution obtained in the step 1), a silicon source and 3-aminopropyl trimethoxy silane, and performing hydrolytic polycondensation reaction to obtain mesoporous organic silicon oxide;
3) And 2) mixing the mesoporous organic silicon oxide obtained in the step 2), water and graphene oxide solution, and performing electrostatic self-assembly to obtain the graphene oxide coated mesoporous organic silicon oxide.
Preferably, the mass ratio of mesoporous organic silica to graphene oxide in the step 3) is 2: (1-2).
Preferably, the activator in the step (1) is EDC solution and NHS solution.
Preferably, the concentration of the EDC solution and the NHS solution are independently 1-2 mg/mL.
Preferably, in the step (1), the mass ratio of the graphene oxide coated mesoporous organic silica to EDC to NHS is 1: (1-1.2): (1-1.4).
Preferably, the temperature of the carboxyl group activation treatment in the step (1) is room temperature, and the time of the carboxyl group activation treatment is 2-3 hours.
Preferably, the mass ratio of the graphene oxide coated mesoporous organic silica in the step (1) to the glucose oxidase in the step (2) is 1: (2-3).
Preferably, the temperature of the condensation reaction in the step (2) is room temperature, and the time of the condensation reaction is 20-24 hours.
The invention also provides the sequential nano catalyst prepared by the preparation method.
The invention provides a preparation method of a sequential nano catalyst, which comprises the following steps: mixing graphene oxide coated mesoporous organic silicon oxide, a first solvent and an activating agent, and performing carboxyl activation treatment to obtain activated graphene oxide coated mesoporous organic silicon oxide; and mixing the activated graphene oxide coated mesoporous organic silicon oxide with glucose oxidase, and performing condensation reaction to obtain the sequential nano catalyst. According to the invention, firstly, carboxyl activation treatment is carried out on the graphene oxide coated mesoporous organic silicon oxide, and then glucose oxidase is connected to the surface of the mesoporous organic silicon oxide through amino-carboxyl condensation reaction, so that the glucose oxidase in the sequential nano catalyst exerts glucose oxidase activity, and the graphene oxide exerts peroxidase activity and photo-thermal property, so that a nano reagent with sequential catalysis is formed. The results of the examples show that GOD exerts glucose oxidase activity and GO exerts peroxidase activity and photo-thermal properties in the sequential nano-catalyst prepared by the preparation method of the invention, and a nano-reagent with sequential catalysis is formed.
Drawings
FIG. 1 is a transmission electron microscope image of PMO in example 1;
FIG. 2 is a transmission electron microscopy image of PMO@GO of example 1;
FIG. 3 is an ultraviolet-visible absorption spectrum of PMO, PMO@GO, GOD, and PMO@GO-GOD of example 1;
FIG. 4 is a Fourier infrared spectrum of PMO@GO and PMO@GO-GOD in example 1;
FIG. 5 shows the color change of PMO@GO-GOD and PMO@GO mixed with a glucose oxidase activity detecting reagent at different concentrations;
FIG. 6 shows absorbance at 500nm after mixing PMO@GO-GOD and PMO@GO with a glucose oxidase activity detecting reagent at different concentrations;
FIG. 7 shows the color change of different groups mixed with equal amounts of H 2O2 and TMB;
FIG. 8 shows absorbance at 652nm after mixing different groups with equal amounts of H 2O2 and TMB;
FIG. 9 shows the temperature change of PMO@GO-GOD solutions of different concentrations irradiated with 808nm (1.0W/cm 2) laser light;
FIG. 10 shows the temperature change of PMO@GO-GOD solution irradiated under 808nm lasers with different powers.
Detailed Description
The invention provides a preparation method of a sequential nano catalyst, which comprises the following steps:
(1) Mixing graphene oxide coated mesoporous organic silicon oxide, a first solvent and an activating agent, and performing carboxyl activation treatment to obtain activated graphene oxide coated mesoporous organic silicon oxide;
(2) And (3) mixing the activated graphene oxide coated mesoporous organic silicon oxide obtained in the step (1) with glucose oxidase, and performing condensation reaction to obtain the sequential nano catalyst.
The source of each raw material is not particularly limited, and commercially available products known to those skilled in the art may be used.
According to the invention, graphene oxide coated mesoporous organic silicon oxide, a first solvent and an activating agent are mixed, and carboxyl activation treatment is carried out, so that activated graphene oxide coated mesoporous organic silicon oxide is obtained.
In the invention, the preparation method of the graphene oxide coated mesoporous organic silicon oxide preferably comprises the following steps:
1) Mixing a surfactant, a second solvent and a catalyst to obtain a mixed solution;
2) Mixing the mixed solution obtained in the step 1), a silicon source and 3-aminopropyl trimethoxy silane, and performing hydrolytic polycondensation reaction to obtain mesoporous organic silicon oxide;
3) And 2) mixing the mesoporous organic silicon oxide obtained in the step 2), water and graphene oxide solution, and performing electrostatic self-assembly to obtain the graphene oxide coated mesoporous organic silicon oxide.
In the present invention, the surfactant, the second solvent and the catalyst are preferably mixed to obtain a mixed solution.
In the present invention, the surfactant is preferably cetyltrimethylammonium bromide or cetyltrimethylammonium chloride.
In the present invention, the second solvent is preferably ethanol and water; the volume ratio of the ethanol to the water is preferably 0.3: (1 to 1.3), more preferably 0.3:1.3.
In the present invention, the catalyst is preferably aqueous ammonia; the mass concentration of the ammonia water is preferably 22-28%, more preferably 25%; the volume ratio of the catalyst to the second solvent is preferably 1: (150 to 160), more preferably 1:160. the catalyst can accelerate the reaction speed and reduce the reaction temperature.
In the present invention, the mixing of the surfactant, the second solvent and the catalyst is preferably performed under stirring conditions; the temperature of the stirring is preferably 30-50 ℃, more preferably 35 ℃; the stirring time is preferably 1 to 2 hours. The stirring speed is not particularly limited, so long as the raw materials are uniformly mixed.
After the mixed solution is obtained, the mixed solution, a silicon source and 3-aminopropyl trimethoxy silane are preferably mixed for hydrolysis and polycondensation reaction to obtain the mesoporous organic silicon oxide.
In the present invention, the silicon source is preferably ethyl orthosilicate and bis [3- (triethoxysilyl) propyl ] tetrasulfide; the volume ratio of the tetraethoxysilane to the bis [3- (triethoxysilyl) propyl ] tetrasulfide is preferably (8-9): 1, more preferably 9:1.
In the present invention, the volume ratio of the second solvent to the silicon source is preferably (700 to 800): 1, more preferably 800:1.
In the present invention, the volume ratio of the mass of the surfactant to the silicon source is preferably (4 to 5) g:10mL, more preferably 4g:10mL.
In the present invention, the volume ratio of the silicon source to 3-aminopropyl trimethoxysilane is preferably 20: (1-2), more preferably 20:1. the invention synthesizes mesoporous organic silicon oxide with positive charges by adopting 3-aminopropyl trimethoxy silane.
In the invention, the mixing of the mixed solution, the silicon source and the 3-aminopropyl trimethoxysilane is preferably performed by rapidly adding the silicon source into the mixed solution and then adding the 3-aminopropyl trimethoxysilane. The invention can be used for quickly adding a silicon source to uniformly nucleate.
The rapid addition operation is not particularly limited in the present invention, and may be performed by an operation well known to those skilled in the art.
In the present invention, the 3-aminopropyl trimethoxysilane is preferably added 15 minutes after the silicon source is added.
In the present invention, the temperature of the hydrolytic polycondensation reaction is preferably room temperature; the hydrolysis polycondensation reaction time is preferably 20 to 30 hours, more preferably 24 hours.
After the hydrolysis and polycondensation reaction is completed, the product obtained by the hydrolysis and polycondensation reaction is preferably subjected to primary centrifugation, washing, extraction, secondary centrifugation, repeated extraction, secondary centrifugation and drying in sequence, so that the mesoporous organic silicon oxide is obtained.
The present invention is not particularly limited to the above-described one-time centrifugation operation, and may be performed by any operation known to those skilled in the art.
In the present invention, the detergent used for the washing is preferably ethanol; the number of times of washing is preferably 3.
In the invention, the extracting agent adopted in the extraction is preferably a mixed solution of concentrated hydrochloric acid and ethanol; the volume ratio of the concentrated hydrochloric acid to the ethanol is preferably 1:500; the temperature of the extraction is preferably 60 ℃; the extraction time is preferably 3 hours. The concentration of the concentrated hydrochloric acid is not particularly limited, and may be any concentration known to those skilled in the art.
The secondary centrifugation operation is not particularly limited, and may be performed by any operation known to those skilled in the art.
In the present invention, the number of times of repeating extraction and secondary centrifugation is preferably 2. The invention can remove the surfactant in the material by adopting extraction and secondary centrifugation.
The drying operation is not particularly limited, and may be performed by any operation known to those skilled in the art.
After mesoporous organic silicon oxide is obtained, the mesoporous organic silicon oxide, water and graphene oxide solution are preferably mixed, and electrostatic self-assembly is carried out to obtain graphene oxide coated mesoporous organic silicon oxide.
In the invention, the mass ratio of the mesoporous organic silicon oxide to the graphene oxide is preferably 2: (1-2), more preferably 2:1.
The water consumption and the concentration of the graphene oxide solution are not particularly limited, so long as the mass ratio of mesoporous organic silicon oxide to graphene oxide is ensured to be 2: (1-2).
In the present invention, the mixing of the mesoporous organic silica, water and the graphene oxide solution is preferably mixing the mesoporous organic silica and water, and then mixing with the graphene oxide solution.
In the present invention, the temperature of the electrostatic self-assembly is preferably room temperature; the time of the electrostatic self-assembly is preferably 20-30 hours, more preferably 24 hours; the electrostatic self-assembly is preferably carried out under light-protected conditions. The invention can prevent raw materials from oxidation by carrying out electrostatic self-assembly under the light-shielding condition.
After the electrostatic self-assembly is completed, the product obtained by the electrostatic self-assembly is preferably subjected to centrifugation and washing in sequence, so that the graphene oxide coated mesoporous organic silicon oxide is obtained.
The operation of the centrifugation and washing is not particularly limited in the present invention, and may be performed by an operation well known to those skilled in the art.
According to the invention, APTES is added to synthesize mesoporous organic silicon oxide with positive charges, the diameter is about 70nm, and then the graphene oxide with negative charges is wrapped on the surface of PMO to obtain PMO@GO, so that the nano particles still keep regular morphology and good dispersibility.
In the present invention, the first solvent is preferably water.
In the present invention, the activator is preferably EDC solution and NHS solution; the concentration of the EDC solution and the NHS solution is independently preferably 1-2 mg/mL; the solvent of the activator is preferably water. The invention adopts the activator to activate carboxyl, which is favorable for the subsequent condensation reaction.
In the invention, the mass ratio of the graphene oxide coated mesoporous organic silicon oxide to EDC to NHS is preferably 1: (1-1.2): (1 to 1.4), more preferably 1:1.2:1.4.
The operation of mixing the graphene oxide coated mesoporous organic silicon oxide, the first solvent and the activating agent is not particularly limited, and the technical scheme for preparing the mixed material, which is well known to the person skilled in the art, can be adopted.
In the present invention, the temperature of the carboxyl group activation treatment is preferably room temperature; the time for the carboxyl group activation treatment is preferably 2 to 3 hours.
After activated graphene oxide coated mesoporous organic silicon oxide is obtained, the activated graphene oxide coated mesoporous organic silicon oxide is mixed with glucose oxidase, and condensation reaction is carried out, so that the sequential nano catalyst is obtained.
In the invention, the mass ratio of the graphene oxide coated mesoporous organic silicon oxide to the glucose oxidase is preferably 1: (2-3), more preferably 1:2.
The operation of mixing the activated graphene oxide coated mesoporous organic silicon oxide and glucose oxidase is not particularly limited, and the technical scheme for preparing the mixed material, which is well known to the person skilled in the art, can be adopted.
In the present invention, the temperature of the condensation reaction is preferably room temperature; the time of the condensation reaction is preferably 20 to 24 hours, more preferably 24 hours.
After the condensation reaction is completed, the invention preferably carries out centrifugation and washing on the product obtained by the condensation reaction in sequence to obtain the sequential nano catalyst.
The operation of the centrifugation and washing is not particularly limited in the present invention, and may be performed by an operation well known to those skilled in the art.
According to the invention, glucose Oxidase (GOD) is connected to the surface of the graphene oxide coated mesoporous organic silicon oxide through an amino-carboxyl condensation reaction, and GOD in the nano particles exerts glucose oxidase activity, GO exerts peroxidase activity and photo-thermal performance, so that a sequentially catalyzed nano reagent is formed.
According to the sequential nano catalyst provided by the invention, the two-dimensional flaky graphene oxide is wrapped on the surface of the spherical mesoporous silicon oxide, so that the cell damage caused by the sharp edge of the two-dimensional material is reduced, and animal experiments show that the nano material has good biocompatibility.
According to the invention, firstly, carboxyl activation treatment is carried out on the graphene oxide coated mesoporous organic silicon oxide, and then glucose oxidase is connected to the surface of the mesoporous organic silicon oxide through amino-carboxyl condensation reaction, so that the glucose oxidase in the sequential nano catalyst exerts glucose oxidase activity, and the graphene oxide exerts peroxidase activity and photo-thermal property, so that a nano reagent with sequential catalysis is formed.
According to the invention, two-dimensional flaky GO is wrapped on the surface of spherical PMO, and Glucose Oxidase (GOD) is loaded on the surface, so that a simple multifunctional nano system PMO@GO-GOD with good biocompatibility and sequential catalytic activity is constructed, and the multifunctional nano system PMO@GO-GOD is used for the catalytic treatment and the combined photothermal treatment of breast cancer; wherein, GO is wrapped on the surface of PMO, which can reduce the damage of the two-dimensional structure to the cell membrane and improve the biocompatibility; the loaded GOD can decompose glucose in the tumor microenvironment into H 2O2, and then GO catalyzes the conversion of H 2O2 into hydroxyl radicals through the peroxidase-like activity of the GOD so as to kill tumor cells; in addition, the GO has higher photo-thermal conversion capability, so that effective photo-thermal treatment can be realized under the irradiation of laser; the PMO@GO-GOD has good glucose oxidase and peroxidase-like activity, and can effectively generate active oxygen. The results of the cell and animal experiments show that PMO@GO-GOD can realize the combination of catalytic treatment and photo-thermal treatment, obviously increase the generation of hydroxyl free radicals and effectively kill tumors. Furthermore, PMO@GO-GOD has good biosafety in vivo.
The invention also provides the sequential nano catalyst prepared by the preparation method.
The technical solutions of the present invention will be clearly and completely described in the following in connection with the embodiments of the present invention. It will be apparent that the described embodiments are only some, but not all, embodiments of the invention. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Example 1
The preparation method of the sequential nano catalyst comprises the following steps:
(1) 0.1g of CTAB, 37.5mL of ethanol, 162.5mL of pure water and 1.25mL of concentrated ammonia water were stirred at 35℃for 1 hour to obtain a mixed solution; wherein the mass concentration of the concentrated ammonia water is 25%;
(2) Fully and uniformly mixing 0.225mLTEOS and 0.025mLTESPTS, quickly adding the mixture into the mixed solution obtained in the step (1), adding 12.5uLAPTES after 15min, continuing to react for 24h, centrifuging, and washing with ethanol for 3 times to obtain a product;
(3) Resuspending the product obtained in the step (2) in a mixed solution of concentrated hydrochloric acid and ethanol with the mass concentration of 37%, stirring for 3 hours at 60 ℃, then repeating the step after centrifugation for three times, and drying to obtain mesoporous organic silicon oxide which is marked as PMO; wherein, the volume ratio of the concentrated hydrochloric acid to the ethanol is 1:500;
(4) Mixing 5mg of mesoporous organic silicon oxide with water, then mixing with graphene oxide solution, stirring for 24 hours at room temperature in a dark place for electrostatic self-assembly, centrifuging, and washing with pure water for 3 times to obtain graphene oxide coated mesoporous organic silicon oxide, which is denoted as PMO@GO; wherein, the mass ratio of mesoporous organic silicon oxide to graphene oxide is 2:1, a step of;
(5) Mixing 1mg of the graphene oxide coated mesoporous organic silicon oxide obtained in the step (4) with 1.2mL of EDC solution and 1.4mLNHS of solution, and activating for 2 hours at room temperature to obtain activated graphene oxide coated mesoporous organic silicon oxide; wherein, the concentration of the EDC solution and the NHS solution is 1mg/mL;
(6) And (3) adding 2mg of GOD into the activated graphene oxide coated mesoporous organic silicon oxide obtained in the step (5), performing condensation reaction for 24 hours at room temperature, centrifuging, and washing with pure water for 3 times to obtain a sequential nano catalyst, which is named as PMO@GO-GOD.
FIG. 1 is a transmission electron microscope image of PMO in example 1; FIG. 2 is a transmission electron microscopy image of PMO@GO of example 1; FIG. 3 is an ultraviolet-visible absorption spectrum of PMO, PMO@GO, GOD, and PMO@GO-GOD of example 1; FIG. 4 is a Fourier infrared spectrum of PMO@GO and PMO@GO-GOD of example 1.
The core of the sequential nanocatalyst prepared in example 1 is mesoporous organic silica, PMO, which is positively charged due to the introduction of amino groups during synthesis, and as can be seen from the electron microscopy image of fig. 1, PMO is a regular spherical particle with a diameter of about 70nm, a surface area of about 1647m 2 g-1, a pore volume of about 1.57cm 3 g-1, and a pore diameter of about 3.7nm; after the graphene oxide is wrapped, the charges of the nano particles PMO@GO are converted into negative charges, and good morphology and dispersibility are maintained; after GOD is connected, the nanoparticle PMO@GO-GOD shows an absorption peak at 970nm, which indicates that GOD is successfully connected; the Fourier infrared spectrum of FIG. 4 shows that PMO@GO-GOD shows absorption peaks of amide bands 1 and 2, indicating successful GOD ligation.
1. Evaluation of glucose oxidase and peroxidase Activity of PMO@GO-GOD prepared in example 1
1. And detecting the glucose oxidase activity of the PMO@GO-GOD by using a glucose oxidase detection kit.
900UL of detection working solution +100 mu LPMO@GO-GOD (different concentrations, 0, 31.25, 62.5, 125 and 250 mu g/mL, calculated as PMO equivalent and prepared by pure water), incubating for 2 hours, and testing the absorbance of the solution at 500nm by using an enzyme-labeled instrument; 900uL of detection working solution +100 mu LPMO@GO (different concentrations, 0, 31.25, 62.5, 125 and 250 mu g/mL, calculated as PMO equivalent, prepared with pure water), incubated for 2h, and the absorbance of the solution at 500nm was measured with an enzyme-labeled instrument as a control group. Wherein each set of experiments included three secondary wells.
FIG. 5 shows the color change of PMO@GO-GOD and PMO@GO mixed with a glucose oxidase activity detecting reagent at different concentrations; FIG. 6 shows absorbance at 500nm after mixing PMO@GO-GOD and PMO@GO with a glucose oxidase activity detection reagent at different concentrations.
As can be seen from fig. 5 and 6, as the pmo@go-GOD concentration increases, the color of the solution changes from colorless to orange-red and increases gradually, with a corresponding increase in absorbance at 500 nm; the control group showed no obvious color or absorbance change, indicating that PMO@GO-GOD had glucose oxidase activity.
2. The peroxidase activity of PMO@GO-GOD was detected using Tetramethylbenzidine (TMB).
TMB, when oxidized, produces a distinct green color. The groups are four: glucose (GLU) +PMO, GLU+PMO@GO, PMO@GO-GOD, GLU+PMO@GO-GOD, concentrations were 250 μg/mL (calculated as PMO equivalent). Each group contained an equal amount of H 2O2 (final concentration 50 mM) and TMB (final concentration 800 nM). After incubation of each group for 30min, the color change was observed and the absorbance at 652nm was measured for each group of solutions.
FIG. 7 shows the color change of different groups mixed with equal amounts of H 2O2 and TMB; FIG. 8 shows absorbance at 652nm after mixing different groups with equal amounts of H 2O2 and TMB.
As can be seen from fig. 7 and 8, the glu+pmo@go group has significantly higher absorbance than the glu+pmo group, indicating that GO does exert peroxidase activity therein; the absorbance of the GLU+PMO@GO-GOD group is significantly higher than that of the GLU+PMO@GO group and the PMO@GO-GOD group, indicating that the amount of H 2O2 can be increased after GOD is connected, thereby enhancing the peroxidase activity of GO.
2. Evaluation of the photo-thermal efficacy of PMO@GO-GOD prepared in example 1
PMO@GO-GOD solutions (0, 0.675,1.25,2.5,5mg/mL, calculated as equivalent PMO, prepared with pure water) of different concentrations were irradiated with a 808nm (1.0W/cm 2) laser, and the change in solution temperature with time was recorded. PMO@GO-GOD solution (3.5 mg/mL, calculated as equivalent amount of PMO) was irradiated with 808nm laser light (0.25,0.5,1.0 and 2.0W/cm 2) at different powers, and the change in solution temperature over time was recorded.
FIG. 9 shows the temperature change of PMO@GO-GOD solutions of different concentrations irradiated with 808nm (1.0W/cm 2) laser light; FIG. 10 shows the temperature change of PMO@GO-GOD solution irradiated under 808nm lasers with different powers.
As can be seen from fig. 9 and 10, the pmo@go-GOD solution temperature increases with increasing irradiation time, and the rate and extent of increase with increasing solution concentration and laser power.
From the above examples, it can be seen that GOD in the sequential nano-catalyst prepared by the preparation method provided by the invention exerts glucose oxidase activity, GO exerts peroxidase activity and photo-thermal property, and a nano-reagent with sequential catalysis is formed.
The foregoing is merely a preferred embodiment of the present invention and it should be noted that modifications and adaptations to those skilled in the art may be made without departing from the principles of the present invention, which are intended to be comprehended within the scope of the present invention.
Claims (10)
1. A method for preparing a sequential nanocatalyst, comprising the steps of:
(1) Mixing graphene oxide coated mesoporous organic silicon oxide, a first solvent and an activating agent, and performing carboxyl activation treatment to obtain activated graphene oxide coated mesoporous organic silicon oxide;
(2) And (3) mixing the activated graphene oxide coated mesoporous organic silicon oxide obtained in the step (1) with glucose oxidase, and performing condensation reaction to obtain the sequential nano catalyst.
2. The preparation method of the graphene oxide coated mesoporous organic silica according to claim 1, wherein the preparation method of the graphene oxide coated mesoporous organic silica in step (1) comprises the following steps:
1) Mixing a surfactant, a second solvent and a catalyst to obtain a mixed solution;
2) Mixing the mixed solution obtained in the step 1), a silicon source and 3-aminopropyl trimethoxy silane, and performing hydrolytic polycondensation reaction to obtain mesoporous organic silicon oxide;
3) And 2) mixing the mesoporous organic silicon oxide obtained in the step 2), water and graphene oxide solution, and performing electrostatic self-assembly to obtain the graphene oxide coated mesoporous organic silicon oxide.
3. The method according to claim 2, wherein the mass ratio of mesoporous organic silica to graphene oxide in step 3) is 2: (1-2).
4. The method of claim 1, wherein the activator in step (1) is EDC solution or NHS solution.
5. The process of claim 4, wherein the EDC solution and NHS solution are independently at a concentration of 1 to 2mg/mL.
6. The preparation method of claim 4, wherein in the step (1), the mass ratio of the graphene oxide coated mesoporous organic silica, EDC and NHS is 1: (1-1.2): (1-1.4).
7. The method according to claim 1, wherein the temperature of the carboxyl group activation treatment in the step (1) is room temperature, and the time of the carboxyl group activation treatment is 2 to 3 hours.
8. The preparation method according to claim 1, wherein the mass ratio of the graphene oxide coated mesoporous organic silica in the step (1) to the glucose oxidase in the step (2) is 1: (2-3).
9. The method according to claim 1, wherein the temperature of the condensation reaction in the step (2) is room temperature, and the time of the condensation reaction is 20 to 24 hours.
10. The sequential nanocatalyst prepared by the method of any of claims 1-9.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410277726.3A CN118165978A (en) | 2024-03-12 | 2024-03-12 | Sequential nano catalyst and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410277726.3A CN118165978A (en) | 2024-03-12 | 2024-03-12 | Sequential nano catalyst and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118165978A true CN118165978A (en) | 2024-06-11 |
Family
ID=91354150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410277726.3A Pending CN118165978A (en) | 2024-03-12 | 2024-03-12 | Sequential nano catalyst and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118165978A (en) |
-
2024
- 2024-03-12 CN CN202410277726.3A patent/CN118165978A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111467491A (en) | Synthesis of platinum modified MOF2-Pt-FA as bidirectional enhanced photodynamic therapy medicine and application of platinum modified MOF2-Pt-FA in tumor therapy | |
CN113398285B (en) | Preparation method of bimetal nano enzyme composite material with anti-tumor effect | |
CN110882216A (en) | Tumor-targeted composite nano enzyme material and preparation method and application thereof | |
CN111097046B (en) | Off-on type visual diagnosis and treatment nano probe | |
CN110960696B (en) | Preparation method of hollow cobalt oxide @ gold platinum nanospheres with biological enzyme activity | |
CN112089836B (en) | Preparation method and application of copper sulfide/hyperbranched macromolecule nano biomimetic enzyme | |
CN113332426A (en) | Preparation method of nano therapeutic agent loaded with iron monoatomic atoms in silicon carrier, nano therapeutic agent obtained by preparation method and application of nano therapeutic agent | |
CN113633660A (en) | Preparation method of bimetallic nano-enzyme composite material with in-situ tumor microenvironment regulation and anti-tumor effect | |
CN110917350B (en) | Preparation and application of black tin dioxide nano photothermal material | |
CN115415512B (en) | Preparation method and application of platinum-zinc oxide heterojunction nano-particles | |
CN118165978A (en) | Sequential nano catalyst and preparation method thereof | |
CN112535739B (en) | Nanoparticle for improving gene transfection efficiency based on tumor self microenvironment and preparation method and application thereof | |
CN118161601A (en) | Application of sequential nano catalyst in preparation of antitumor drugs | |
CN114949186A (en) | POD-GOD (peroxidase-GOD) synergistically modified mesoporous silicon nanomaterial, preparation method and application | |
CN114533858B (en) | Acid-response nano-drug capable of continuously releasing hydroxyl free radical and singlet oxygen as well as preparation method and application thereof | |
CN114668853B (en) | Allicin-containing tumor in-situ response nanoparticle and preparation and application thereof | |
CN114601927A (en) | Monoatomic platinum composite cerium dioxide nano particle for tumor electrokinetic force treatment and preparation thereof | |
CN114796486B (en) | Preparation method and application of platinum/titanium dioxide @ manganese dioxide-polyethyleneimine composite anticancer nanomaterial | |
CN116196438B (en) | Preparation method of oxidation-responsive nano preparation | |
CN118045201A (en) | PtSe modified by murine serum albumin2Preparation method and application of quantum dot | |
CN117100858A (en) | Preparation method and application of multifunctional cerium oxide nano enzyme platform with cascade reaction | |
Ye et al. | Fe-doped biodegradable dendritic mesoporous silica nanoparticles for starvation therapy and photothermal-enhanced cascade catalysis in tumor therapy | |
CN116327935A (en) | Cobalt ferrite@platinum polyethylene glycol composite anticancer nanomaterial and preparation method thereof | |
CN115944728A (en) | Multifunctional composite nano enzyme material for tumor synergistic treatment and preparation method and application thereof | |
CN118141937A (en) | Multifunctional nano platform, preparation method thereof and anti-tumor application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |